Latest Competition News

Biotron Limited has engaged US-based C14 Consulting Group to drive strategic partnerships for its antiviral drug portfolio, including lead candidate BIT225, while advancing its Hepatitis B research.

Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.

Amcor plc and Berry Global Group have filed their definitive joint proxy statement with the SEC, marking a key milestone in their planned all-stock merger. Shareholder meetings are scheduled for February 25, 2025, as the companies aim to create a global packaging powerhouse.

Kogan.com reports robust first-half FY25 results with double-digit growth in sales and profits, driven by strategic marketing and a major digital upgrade at Mighty Ape despite initial setbacks.

IGO Limited has ceased all work on Lithium Hydroxide Plant 2 at its Kwinana Refinery, anticipating a substantial impairment loss in its upcoming half-year financial results.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.

DeSoto Resources has secured a strategic manganese project in Brazil and received pioneering drilling approvals in Australia's Northern Territory, setting the stage for significant exploration activity in 2025.

Brazilian Critical Minerals Ltd reports breakthrough test results from its Ema ionic clay rare earth project, producing a high-purity mixed rare earth carbonate and advancing drilling, logistics, and environmental assessments.

BSA Limited reported a robust Q2 FY2025 with revenue up 10.7% and EBITDA surging 31.5%, underpinned by a key contract extension with nbn. The company has upgraded its full-year EBITDA guidance, signaling confidence in sustained profitability.

Aquirian’s subsidiary Western Energetics has secured a $20 million, three-year supply agreement with Mt Ida Goldmine, delivering innovative energetics and technology solutions that promise cost savings and environmental benefits.

Biome Australia Limited has expanded its distribution footprint to over 6,000 health retail and practitioner locations, marking a 20% increase in six months and advancing toward its Vision 27 target of 8,000 sites by FY27.

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.